The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
2021 · Nature · 436 citations
https://doi.org/10.1038/s41586-021-03341-5
M
Mustafa Yalçınkaya
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.4K
Citations
16
h-index
18
i10-index
Mustafa Yalçınkaya is an academic researcher from Columbia University. The author has contributed to research in topics: Inflammasome and immune disorders & Cholesterol and Lipid Metabolism & Atherosclerosis and Cardiovascular Diseases. The author has an h-index of 16, co-authored 29 publications.
ORCID: 0000-0003-2199-0886Papers by this author
worksCholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion
2022 · Cardiovascular Research · 86 citations
https://doi.org/10.1093/cvr/cvac189
Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein
2021 · Scientific Reports · 75 citations
https://doi.org/10.1038/s41598-021-04133-7
Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis
2024 · Journal of Lipid Research · 25 citations
https://doi.org/10.1016/j.jlr.2024.100534
Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma
2018 · Journal of Lipid Research · 20 citations
https://doi.org/10.1194/jlr.m083311
Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways
2023 · Cardiovascular Research · 12 citations
https://doi.org/10.1093/cvr/cvad183
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat